SincalideHormone TherapySafety Rating 8/10

Primary research areaGallbladder and pancreatic function testing

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range0.02 mcg/kg IV over 30-60 min
AdministrationIntravenous
Safety8/10 · FDA-approved (Kinevac)
NCAA D1Not listed

Price Comparison

Compare vendors

No vendor pricing available for this peptide yet.

Overview

About Sincalide

Mechanism of action

CCK-8 analog; stimulates gallbladder contraction and pancreatic enzyme secretion

Safety profile

Nausea, vomiting, abdominal cramps; diagnostic use · Decades of diagnostic use; abdominal cramps transient; well-established

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Sincalide

Failed to fetch